Artesunate and a major metabolite, dihydroartemisinin, diminish MITOGEN-induced lymphocyte proliferation and activation

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 37, Issue 5, 2006, Pages 838-847

  Veerasubramanian, P ^a   Gosi, P ^a   Limsomwong, C ^a   Walsh, D S ^a,b  

^a ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^b Walter Reed Project HIV Program   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33751582721     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Benakis A, Paris M, Loutan L, Plessas CT, Plessas ST. Pharmacokinetics of artemisinin and artesunate after oral administration in healthy volunteers. Am J Trop Med Hyg 1997; 56:17-23.
2. Bethell DB, Teja Isavadharm P, Cao XT, et al. Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 1997; 91: 195-8.
3. Brewer TG, Peggins JO, Grate SJ, et al. Neurotoxicity in animals due to arteether and artemether. Trans R Soc Trop Med Hyg 1994; 88 (suppl 1): S33-6.
4. Caceres-Dittmar G. Tapia FJ, Sanchez MA, et al. Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin Exp Immunol 1993; 91; 500-5.
5. Chen H. Maibach HI. Topical application of artesunate on guinea pig allergie contact dermatitis. Contecr Dermat 1994; 30; 280-2.
6. Chen M, Kappel M, Lemnge M, Bygbjerg IC, Theander TG, Kharazmi A, In vitro effects of artesunate and other antimalarial agents on the function of human Iymphocytes and neutrophils. Transplant Proc 1994; 26: 3172-4.
7. De Paolo P, Reitano M, Battistin S, Castiglia C, Santini G. Enumeration of human lymphocyte subsets by monoclonal antibodies and flow cytometry: a comparative study using whole blood or mononuclear cells separated by density gradient centrifugation. J Immunol Meth 1984; 72: 349-53.
8. Fishwick J, Edwards G, Ward SA, McLean WG. Binding of dihydroartemisinin to differentiating neuroblastoma cells and rat cortical homogenate. Neurotoxicology 1998a; 19: 405-12.
9. Fishwick J, Edwards G, Ward SA, McLean WG. Morphological and immunocytochemical effects of dihydroartemisinin on differentiating NB2a neuroblastoma cells. Neurotoxicology 1998b; 19:393-403.
10. Guojun H, Yi Z. Experimental studies of the effect of sodium artesunate on the immune function in mice. J Trad Chin Med 1983; 3: 171-6.
11. He XL, Liu Z. [Protection of artesunate on activation and injury of vascular endothelial cells induced by lipopolysaccharide]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004; 24: 1110-3.
12. Hien TT, White NJ. Qinghaosu. Lancet 1993; 6; 341 : 603-8.
13. Isaacson DI, Elgart M, Turner ML, Anti-malarials in dermatology. Int JDermatol 1982; 21: 379-95.
14. Ittarat W, Udomsangpetch R, Chotivanich KT, Looareesuwan S. The effects of quinine and artesunate treatment on plasma tumor necrosis factor levels In malaria-infected patients, Southeast Asian J Trop Med Public Health 1999; 30: 7-10.
15. Koranda FC. Antimalarials. J Am Acad Dermatol 1981; 4: 650-5.
16. Kwiatkowski D, Bate C. Inhibition of tumour necrosis factor (TNF) production by antimalarial drugs used in cerebral malaria. Trans R Soc Trop Med Hyg 1995; 89: 215-6.
17. Noori S, Naderi GA, Hassan ZM, Habibi Z, Bathaie SZ, Hashemi SM, Immunosuppressive activity of a molecule isolated from Artemisia annua on DTH responses compared with cyclosporin A. Int Immunopharmacol 2004; 4: 1301-6.
18. Othoro C, Lal AA, Nahlen B, Koech D, Orago AS, Udhayakumar V. A low interleukin-10 tumor necrosis factor-α ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J Infect Dis 1999; 179: 279-82.
19. Pichyangkul S, Yongvanitchit K, Kum-arb U, Krieg AM, Heppner DG, Walsh DS. Whole blood cultures to assess the immunostimulatory activities of CpG oligodeoxynucleotides. J Immunol Methods 2001; 247: 83-94.
20. Pirmez C, Yamamura M, Uyemura K, Paes Oliveira M, Conceicao Silva F, Modlin RL. Cytokine patterns in the pathogenesis of human leish-maniasls, J Clin Invest 1993; 91: 1390-5,
21. Tawfik AF, Bishop SJ, Ayalp A, el Feraly FS. Effects of artemisinin, dihydroartemlsinin and arteether on immune responses of normal mice. Int J Immunopharmacol 1990; 12; 385-9.
22. Teja-Isavadharm P, Mosten F, Kyle DE, et al. Comparative bioavailability of oral, rectal, and intramuscular artemether in healthy subjects: use of simultaneous measurement by high performance liquid chromatography and bioassay. Br J Clin Pharmacol 1996; 42: 599-604.
23. Udomsangpetch R, Pipitaporn B, Krishna S, et al. Antimalarial drugs reduce cytoadherence and resetting Plasmodium falciparum. J Infect Dis 1996; 173: 691-8.
24. Wenisch C, Parschalk B, Zedwitz-Liebensteln K, Wernsdorfer W, Graninger W. The effect of artemisinin on granulocyte function assessed by flow cytometry. J Antimicrob Chemother 1997: 39: 99-101.
25. Wilairatana P, Krudsood S, Silachamroon U, et al. Clinical trial of sequential treatments of moderately severe and severe malaria with dihydroartemisinin suppository followed by mefloquine in Thailand. Am J Trop Med Hyg 2000; 63: 290-4.
26. Yang SX, Xie SS, Gao HL, Long ZZ. Artemisinin and its derivatives enhance T Iymphocyte-mediated immune responses in normal mice and accelerate immunoreconstitution of mice with syngeneic bone marrow transplantation. Clin Immunol Immunopathol 1993; 69: 143-8.